Logo image of UPR.I

UNIPHAR PLC (UPR.I) Stock Price, Quote, News and Overview

DUB:UPR - Euronext Dublin - IE00BJ5FQX74 - Common Stock - Currency: EUR

2.71  +0.01 (+0.37%)

UPR.I Quote, Performance and Key Statistics

UNIPHAR PLC

DUB:UPR (3/7/2025, 7:00:00 PM)

2.71

+0.01 (+0.37%)

Sector
GICS SectorHealth Care
GICS IndustryHealth Care Providers & Services
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Distributors
Statistics
52 Week High2.9
52 Week Low1.9
Market Cap703.60M
Shares259.63M
Float244.92M
Yearly Dividend0.02
Dividend Yield0.87%
PE15.94
Fwd PE11.9
Earnings (Next)09-01 2025-09-01
IPO07-17 2019-07-17


UPR.I short term performance overview.The bars show the price performance of UPR.I in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 5 10 15 20

UPR.I long term performance overview.The bars show the price performance of UPR.I in the last 1, 2 and 3 years. 1 year 2 years 3 years -5 -10 -15 -20 -25

The current stock price of UPR.I is 2.71 EUR. In the past month the price increased by 11.52%. In the past year, price decreased by -2.69%.

UNIPHAR PLC / UPR Daily stock chart

UPR.I Competitors/Peers

The largest stocks on the EU markets in the "Health Care Distributors" sub-industry
Full List
Symbol
Name
TA
FA
PE
Market Cap
AMP.MI AMPLIFON SPA 30.68 4.72B
FAGR.BR FAGRON 17.45 1.35B
ILM1.DE MEDIOS AG 25.09 339.28M
BLC.PA BASTIDE LE CONFORT MEDICAL N/A 184.37M
TLIK.DE ARZNEIWERK AG VIDA N/A 3.03M

About UPR.I

Company Profile

UPR logo image Uniphar Plc engages in the provision of services within the pharmaceutical and healthcare sector. The company is headquartered in Dublin, Dublin and currently employs 3,262 full-time employees. The company went IPO on 2019-07-17. The firm is focused on improving access to pharmaco-medical products and therapies. The company operates through three divisions: Uniphar Medtech, Uniphar Pharma, and Uniphar Supply Chain & Retail. Its Uniphar Medtech division provides outsourced services, specifically sales, distribution and support services to medical device manufacturers. Uniphar Pharma division operates a global business with valued services across the lifecycle of a pharmaceutical product. This division operates through its on demand and pharma services business units. Uniphar Supply Chain & Retail division provides both pre-wholesale and wholesale distribution of pharmaceutical, healthcare and animal health products to pharmacies, hospitals and veterinary surgeons in Ireland. The company operates a network of pharmacies under the Life, Allcare, Hickey’s and McCauleys brands. The company also provides services and support that help independent community pharmacies.

Company Info

UNIPHAR PLC

4045 Kingswood Drive, Citywest Business Park

DUBLIN DUBLIN IE

Employees: 3000

Company Website: https://www.uniphar.ie/

Investor Relations: http://www.uniphar.ie/static/investors/investor-overview/

Phone: 35314287777

UNIPHAR PLC / UPR.I FAQ

What is the stock price of UNIPHAR PLC today?

The current stock price of UPR.I is 2.71 EUR. The price increased by 0.37% in the last trading session.


What is the ticker symbol for UNIPHAR PLC stock?

The exchange symbol of UNIPHAR PLC is UPR and it is listed on the Euronext Dublin exchange.


On which exchange is UPR.I stock listed?

UPR.I stock is listed on the Euronext Dublin exchange.


What is the price forecast or stock price prediction for UNIPHAR PLC stock?

10 analysts have analysed UPR.I and the average price target is 4.63 EUR. This implies a price increase of 70.7% is expected in the next year compared to the current price of 2.71. Check the UNIPHAR PLC stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is UNIPHAR PLC worth?

UNIPHAR PLC (UPR.I) has a market capitalization of 703.60M EUR. This makes UPR.I a Small Cap stock.


How many employees does UNIPHAR PLC have?

UNIPHAR PLC (UPR.I) currently has 3000 employees.


What are the support and resistance levels for UNIPHAR PLC (UPR.I) stock?

UNIPHAR PLC (UPR.I) has a support level at 2.57 and a resistance level at 2.72. Check the full technical report for a detailed analysis of UPR.I support and resistance levels.


Is UNIPHAR PLC (UPR.I) expected to grow?

The Revenue of UNIPHAR PLC (UPR.I) is expected to grow by 8.94% in the next year. Check the estimates tab for more information on the UPR.I EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy UNIPHAR PLC (UPR.I) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does UNIPHAR PLC (UPR.I) stock pay dividends?

UNIPHAR PLC (UPR.I) has a dividend yield of 0.87%. The yearly dividend amount is currently 0.02. Check the full fundamental report for a detailed analysis of UPR.I dividend history, reliability and sustainability.


When does UNIPHAR PLC (UPR.I) report earnings?

UNIPHAR PLC (UPR.I) will report earnings on 2025-09-01.


What is the Price/Earnings (PE) ratio of UNIPHAR PLC (UPR.I)?

The PE ratio for UNIPHAR PLC (UPR.I) is 15.94. This is based on the reported non-GAAP earnings per share of 0.17 and the current share price of 2.71 EUR. Check the full fundamental report for a full analysis of the valuation metrics for UPR.I.


UPR.I Technical Analysis

ChartMill assigns a technical rating of 8 / 10 to UPR.I. When comparing the yearly performance of all stocks, UPR.I turns out to be only a medium performer in the overall market: it outperformed 65.66% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

UPR.I Fundamental Analysis

ChartMill assigns a fundamental rating of 4 / 10 to UPR.I. While UPR.I is still in line with the averages on profitability rating, there are concerns on its financial health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

UPR.I Financial Highlights

Over the last trailing twelve months UPR.I reported a non-GAAP Earnings per Share(EPS) of 0.17. The EPS increased by 1.35% compared to the year before.


Industry RankSector Rank
PM (TTM) 1.68%
ROA 3.18%
ROE 12.9%
Debt/Equity 1.14
Chartmill High Growth Momentum
EPS Q2Q%9.46%
Sales Q2Q%10.33%
EPS 1Y (TTM)1.35%
Revenue 1Y (TTM)15.64%

UPR.I Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 82% to UPR.I. The Buy consensus is the average rating of analysts ratings from 10 analysts.

For the next year, analysts expect an EPS growth of 8.13% and a revenue growth 8.94% for UPR.I


Ownership
Inst Owners44.92%
Ins Owners5.43%
Short Float %N/A
Short RatioN/A
Analysts
Analysts82
Price Target4.63 (70.85%)
EPS Next Y8.13%
Revenue Next Year8.94%